Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1326-1330

  Nakai, Reiko ^a   Maniwa, Yoshimasa ^a   Tanaka, Yugo ^a   Nishio, Wataru ^a   Yoshimura, Masahiro ^a   Okita, Yutaka ^a   Ohbayashi, Chiho ^a   Satoh, Naoyuki ^a   Ogita, Hisakazu ^a   Takai, Yoshimi ^a   Hayashi, Yoshitake ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NECTIN LIKE MOLECULE 5; ONCOPROTEIN; PROTEIN NECL 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK FACTOR; TUMOR CLASSIFICATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, VIRUS;

EID: 77953192863     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01530.x     Document Type: Article

References (31)

1. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. Nectins and nectin-like molecules: Roles in cell adhesion, migration, and polarization. Cancer Sci 2003, 94:655-67.
2. Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56:855-65.
3. Koike S, Horie H, Ise I. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 1990, 9:3217-24.
4. Faris RA, McEntire KD, Thompson NL, Hixson DC. Identification and characterization of a rat hepatic oncofetal membrane glycoprotein. Cancer Res 1990, 50:4755-63.
5. Douillard JY, Laborda J, Burg C. Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors. Cancer Res 1989, 49:687-92.
6. Chadeneau C, Denis MG, Blottiere HM, Gregoire M, Douillard JY, Meflah K. Characterization, isolation and amino terminal sequencing of a rat colon carcinoma-associated antigen. Int J Cancer 1991, 47:903-8.
7. Chadeneau C, LeMoullac B, Denis MG. A novel member of the immunoglobulin gene superfamily expressed in rat carcinoma cell lines. J Biol Chem 1994, 269:15601-5.
8. Lim YP, Fowler LC, Hixson DC, Wehbe T, Thompson NL. TuAg.1 is the liver isoform of the rat colon tumor-associated antigen pE4 and a member of the immunoglobulin-like supergene family. Cancer Res 1996, 56:3934-40.
9. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A 2000, 97:6803-8.
10. Masson D, Jarry A, Baury B. Overexpression of the CD155 gene in human colorectal carcinoma. Gut 2001, 49:236-40.
11. Sloan KE, Eustace BK, Stewart JK. CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 2004, 4:73.
12. Baury B, Geraghty RJ, Masson D, Lustenberger P, Spear PG, Denis MG. Organization of the rat Tage4 gene and herpesvirus entry activity of the encoded protein. Gene 2001, 265:185-94.
13. Ravens I, Seth S, Förster R, Bernhardt G. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155. Biochem Biophys Res Commun 2003, 312:1364-71.
14. Ikeda W, Kakunaga S, Itoh S. Tage4/nectin-like molecule-5 heterophilically trans-Interacts with cell adhesion molecule nectin-3 and enhances cell migration. J Biol Chem 2003, 278:28167-72.
15. Ikeda W, Kakunaga S, Takekuni K. Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, nectin-3-independent manner. J Biol Chem 2004, 279:18015-25.
16. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-14.
17. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001, 81:153-208.
18. Mitchison TJ, Cramer LP. Actin-based cell motility and cell locomotion. Cell 1996, 84:371-9.
19. Kakunaga S, Ikeda W, Shingai T. Enhancement of serum-and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling. J Biol Chem 2004, 279:36419-25.
20. Mueller S, Wimmer E. Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to αvβ3 integrin-containing membrane microdomains. J Biol Chem 2003, 278:31251-60.
21. Sato T, Irie K, Ooshio T, Ikeda W, Takai Y. Involvement of heterophilic trans-interaction of Necl-5/Tage4/PVR/CD155 with nectin-3 in formation of nectin- and cadherin-based adherens junctions. Genes Cells 2004, 9:791-9.
22. Fujito T, Ikeda W, Kakunaga S. Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3. J Cell Biol 2005, 171:165-73.
23. Erickson BM, Thompson NL, Hixson DC. Tightly regulated induction of the adhesion molecule Necl-5/CD155 during rat liver regeneration and acute liver injury. Hepatology 2006, 43:325-34.
24. Abe A, Fukui H, Fujii S. Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate. J Pathol 2009, 217:42-53.
25. Morimoto K, Satoh-Yamaguchi K, Hamaguchi A. Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs. Oncogene 2008, 27:264-73.
26. Noguchi M, Morikawa A, Kawasaki M. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-52.
27. Martini N, Bains MS, Burt ME. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-9.
28. Harpole DH, Herndon JE, Young WG, Wolfe WG, Sabiston DC. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995, 76:787-96.
29. Al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 1997, 12:380-4.
30. Chadeneau C, LeCabellec M, LeMoullac B, Meflah K, Denis MG. Over-expression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas. Int J Cancer 1996, 68:817-21.
31. Tokunou M, Niki T, Eguchi K. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol 2001, 158:1451-63.